Immunai's engineering-first platform maps the immune system for the discovery and augmentation of novel therapeutics, through single-cell sequencing, functional genomics, big data and ML. Immunai holds a successful track record of partnering with leading pharmaceutical and biotech companies, academic institutions and hospitals to optimize their preclinical and clinical decision-making. To learn more, please visit https://www.immunai.com/

Suttons Creek is pharma’s device team. Any life sciences company going to market with a drug delivery system needs a device team experienced in combination products working alongside their drug team. That device team includes specialists in areas like quality, regulatory, vendor selection and management, systems engineering, risk management, clinical development, human factors, and commercialization. Suttons Creek has over 650 years of combined experience and 120+ combination product projects under its belt. Our talent pool of subject matter experts specializes in all device-related aspects of the combination product lifecycle, from strategic planning through development to launch and postmarket activities. Our history of success proves that hiring our experienced device team results in faster time to market, reduced risk, improved patient experience and adherece, and lower overall cost (higher profit). For more information, visit https://suttonscreek.com/

Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.

HistoWiz accelerates scientific research and discoveries by automating histology and digital pathology solutions. The company is a leading provider of end-to-end solutions for digital pathology, offering comprehensive services from slide creation to digitization, image analysis, and pathology consultations. Its platform, PathologyMapTM, empowers researchers with tools for efficient image management and analysis. Through automation and AI, HistoWiz’s innovations promote a deeper understanding of biology by enabling global collaboration to drive scientific advancement. HistoWiz was founded in 2013 and is headquartered in Long Island City, New York. 

Radiant Biotherapeutics is a revolutionary antibody platform company leading the next frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. Radiant’s proprietary Multabody™ platform leverages avidity and multi-specificity simultaneously, to generate highly efficacious Multabodies with superior potency than other antibody platforms. These powerful Multabodies have potential to deliver a new class of biologics to tackle complex, heterogenous diseases, such as cancer, that often have challenging targets and mechanisms. Multabody™ production and manufacturing is flexible, modular and scalable, and leverages standard antibody CMC processes. The ground-breaking efficiency of the platform is driving a novel pipeline of mono-, bi- and tri-specific biologics in multiple therapeutics areas. With offices in Toronto and Philadelphia, Radiant has forged multiple strategic partnerships that validate the Multabody™ platform’s broad scientific and clinical utility. For more, visit radiantbio.com.

Putnam, an Inizio Advisory company, is a leading scientific and strategic consulting partner that helps the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients. For more than 30 years, our rigorous, bespoke approach and globally diverse team have delivered unrivaled depth across therapeutic areas, business functions, geographic markets, healthcare sectors, and technology platforms to maximize the human impact and commercial success of client innovations. To learn more, please visit https://www.putassoc.com/ 

PPD, part of Thermo Fisher Scientific, provides clinical development and analytical services that enhance customer innovation and productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, patient recruitment, investigator sites and comprehensive laboratory service. To learn more, please visit https://www.ppd.com/

TREND Community turns the conversations of people who have rare, chronic, and emerging diseases and their caregivers/care partners into actionable insights through our proprietary evidence-accelerator approach. Above all, we prioritize the privacy and trust of every community member. For more information visit https://trend.community.

Innovative Trials is a prominent international company specializing in patient recruitment and retention for clinical trials. Boasting 14 years of experience, Innovative Trials provides three fundamental services in this domain: Site Enrollment Optimization, facilitated by ‘boots-on-the-ground’ local patient recruitment expert operating in more than 70 countries, Materials & Digital Advertising services, and Navigator, a 1:1 support service for patients, caregivers and sites. With expertise in over 300 trials, spanning 25 therapeutic areas and encompassing over 90 conditions, Innovative Trials has established itself as a trusted and seasoned partner for pharmaceutical companies, contract research organizations (CROs) and biotechnology companies. To learn more, please visit https://innovativetrials.com/

Specialized in developing genetically engineered mouse models, GenoBioTX proudly offers an inventory of 9000 catalog mouse models and has successfully customized over 19,000 strains for clients. GenoBioTX also provide more than 600 humanized mouse models for drug discovery. Beyond this, GenoBioTX has expanded into pre-clinical CRO services across diverse disease areas, especially immuno-oncology. Our commitment to innovation and client satisfaction continues to drive our success in the dynamic field of drug discovery. For more information, go to https://www.modelorg.com/en/.

Lyophilization Technology, Inc. (LTI) is a premier contract development and manufacturing organization (CDMO) and industry leader in pharmaceutical, biologics, diagnostic, combination, and medical-device lyophilization. Offering formulation development, thermal/cycle optimization, dual-chamber device services, seamless clinical-trial supply manufacturing, potent-material containment as well as, expert consulting, customized training, and technical support. LTI delivers innovative, regulatory-ready, and client-focused solutions that overcome your most demanding scientific challenges.

RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development. For more information, go to https://rarecyte.com/